ADA 2025 Recap: Medical Affairs
Medical Affairs (+Research and Advocacy) Breakthrough T1D’s Medical Affairs program is bridging the gap between access to and adoption of therapies, treatments, drugs, and devices for T1D. To accomplish this goal, the Medical Affairs team is working on healthcare provider (HCP) education, development of clinical care guidelines, and clinical trial education and awareness. Breakthrough T1D’s […]
Breakthrough T1D helps organize an event at the European Parliament about unmet needs for T1D and accelerating cures
This meeting focused on the role of the EU in addressing the needs of the T1D community and accelerating T1D breakthroughs.
The essential role of Advocacy in advancing T1D cell therapies
Breakthrough T1D's Advocacy efforts contribute to clear and efficient policies and secure government funding for manufactured cell therapies.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key steps we can take to meet these needs. The other used real-world data to better understand American T1D demographics and predict changes in the next decade.
Challenges and solutions: The present and future of cell therapies for T1D
Breakthrough T1D is funding research that supports manufactured islet cell source, survival, and protection and is also driving initiatives to unlock access to manufactured islet therapies for people with T1D.
Breakthrough T1D 2025 Government Day: 4 amazing days, 485 Congressional meetings, 370 sore feet
Breakthrough T1D headed to Washington D.C. where advocates held nearly 500 meetings with Members of Congress on behalf of the T1D community.
2024 greatest T1D hits: A glance at this year’s achievements
While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures and improving everyday life with T1D. This wouldn’t have been possible without each and every one of you and your continued support of our mission as we drive toward cures for T1D. Here are the […]
Orlando Brown, Jr. nominated for Walter Payton NFL Man of the Year Award
Orlando Brown, Jr. has been nominated for the Man of the Year Award in recognition of his outreach work with Breakthrough T1D.
Meet Orlando Brown, Jr., a hero for T1D advocacy
Orlando Brown, Jr.'s commitment to type 1 diabetes (T1D) advocacy stems from his family’s journey with the disease.
Moving T1D forward through advocacy
Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.
